Third-party Payer Litigation

Third-Party Payer Litigation is a type of civil legal action initiated by entities that reimburse or pay for prescription drugs to recover financial losses incurred due to the alleged marketing or sale of defective pharmaceuticals, distinguished from direct consumer or patient lawsuits by the litigant's role as an indirect payer rather than an end-user of the medication.

2

Publications

48

Citations

3

Authors

3

Institutions

Publications per year

2017–2026

0

Authors

3

  1. TA
    Troyen A. Brennan

    Brigham and Women's Hospital, United States

    1 publications · 25 citations

    1

    h-index

  2. AS
    Aaron S. Kesselheim

    Brigham and Women's Hospital, United States

    1 publications · 25 citations

    1

    h-index

  3. LN
    Lee N. Newcomer

    Yale University, United States

    1 publications · 23 citations

    1

    h-index

1–3 of 3

Institutions

3

  1. Harvard University

    Cambridge, United States

    1 h-index

    1 publications

    25 citations

  2. Plan International

    Washington D.C., United States

    1 h-index

    1 publications

    23 citations

  3. Brigham and Women's Hospital

    Boston, United States

    1 h-index

    2 publications

    50 citations

1–3 of 3

Venues

  1. New England Journal of Medicine

    NEJM · 2 publications · 48 citations

    2

    h-index

1–1